Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

News | Peripheral Artery Disease (PAD)

March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II ...

Home March 22, 2016
Home
Intact Vascular, Tack Endovascular System
Feature | Peripheral Artery Disease (PAD) | Dave Fornell

It is estimated that more than 10 million people in the United States are affected by peripheral arterial disease (PAD) ...

Home February 22, 2016
Home
News | Peripheral Artery Disease (PAD)

January 29, 2016 — Intact Vascular Inc. announced that positive six-month results from its Tack Optimized Balloon ...

Home January 29, 2016
Home
News | Drug-Eluting Balloons

January 18, 2016 — Medtronic plc announced that the IN.PACT Admiral drug eluting balloon (DEB) has received CE ...

Home January 18, 2016
Home
Technology | Balloon Catheter

January 12, 2016 — NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) ...

Home January 12, 2016
Home
Feature | Cath Lab

November 24, 2015 — The U.S. Food and Drug Administration (FDA) issued a warning this week that hydrophilic and/or ...

Home November 24, 2015
Home
Videos | Balloon Catheter

Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford ...

Home October 30, 2015
Home
ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis
Feature | Drug-Eluting Balloons

October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated ...

Home October 22, 2015
Home
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery
Feature | Peripheral Artery Disease (PAD)

October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a drug-coated balloon was superior to co ...

Home October 18, 2015
Home
News | Drug-Eluting Balloons

October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-World ...

Home October 15, 2015
Home
News | Cath Lab

October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiovascular space including the latest ...

Home October 09, 2015
Home
News | Peripheral Artery Disease (PAD)

October 1, 2015 — Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval ...

Home October 01, 2015
Home
News | Cath Lab

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...

Home August 26, 2015
Home
C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
Feature | Drug-Eluting Balloons

July 8, 2015 - C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online ...

Home July 08, 2015
Home
Subscribe Now